Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
1.180
-0.180 (-13.24%)
At close: Jun 3, 2026, 4:00 PM EDT
1.180
0.00 (0.00%)
Pre-market: Jun 4, 2026, 8:19 AM EDT

Tiziana Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1533616111220
Market Cap Growth
-7.51%131.38%35.23%-6.49%-37.50%-75.02%
Enterprise Value
149.0332.1411.810.4-5.61-22.55
Last Close Price
1.181.490.700.560.600.96
PB Ratio
2934.28690.603.942.070.630.48
P/TBV Ratio
536.82677.853.772.070.620.46
EV/EBITDA Ratio
----0.390.83
EV/EBIT Ratio
----0.380.82
EV/FCF Ratio
----0.291.04
Debt / Equity Ratio
4.504.5000.020.010
Net Debt / Equity Ratio
-68.35-68.35-0.92-0.17-0.91-1.02
Net Debt / EBITDA Ratio
0.170.170.230.051.221.55
Net Debt / FCF Ratio
0.280.282.340.060.911.94
Quick Ratio
0.720.721.001.093.606.28
Current Ratio
0.760.761.021.123.646.45
Return on Equity (ROE)
-282.45%-924.32%-353.59%-137.35%-50.61%-45.18%
Return on Assets (ROA)
-185.54%-185.54%-134.60%-93.03%-38.74%-40.25%
Return on Invested Capital (ROIC)
1597.88%1597.88%-638.92%-558.77%-1278.35%16084.90%
Return on Capital Employed (ROCE)
-1001.04%-1001.04%-329.69%-141.28%-47.75%-52.66%
Buyback Yield / Dilution
-10.88%-10.88%-4.10%-0.93%-3.67%-0.64%
Total Shareholder Return
-10.88%-10.88%-4.10%-0.93%-3.67%-0.64%
SEC Filings: 10-K · 10-Q